Literature DB >> 8073366

On the use of affected controls to address recall bias in case-control studies of birth defects.

M J Khoury1, L M James, J D Erickson.   

Abstract

Inferences regarding causes of birth defects in humans are often based on results of case-control studies conducted after birth. To address bias in these studies caused by potential differential recall of past exposures between case and control mothers, many investigators have advocated the use of affected controls (babies with birth defects other than the one of interest). To evaluate whether the use of affected controls is warranted for a wide range of scenarios, we analyzed data from a population-based case-control study of birth defects in Atlanta, in which there were 4,918 babies with serious defects ascertained in the first year of life and 3,029 babies without defects. We compared the magnitude of the odds ratios for 10 specific defects--risk factor associations between normal and affected controls. These associations included demographic factors (e.g., advanced maternal age and Down syndrome), chronic maternal illnesses (e.g., diabetes and cardiac defects), chronic exposures (e.g., multivitamins and neural tube defects), and acute exposures (e.g., flu and neural tube defects). In all instances, the use of affected controls did not change etiologic inferences derived from using normal controls and there were only moderate changes in odds ratios. On the basis of theoretical considerations, we show that recall bias can lead to spurious inferences only under extreme conditions. We conclude that concerns about recall bias are overrated in birth defects studies and that the use of normal controls is acceptable unless evidence of substantial recall bias exists.

Entities:  

Mesh:

Year:  1994        PMID: 8073366     DOI: 10.1002/tera.1420490407

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  17 in total

1.  Prospective recruitment of women receiving prenatal care from diverse provider arrangements: a potential strategy.

Authors:  A Handler; D Rosenberg; T Johnson; K Raube; M A Kelley
Journal:  Matern Child Health J       Date:  1997-09

2.  Using bayesian models to assess the effects of under-reporting of cannabis use on the association with birth defects, national birth defects prevention study, 1997-2005.

Authors:  Marleen M H J van Gelder; A Rogier T Donders; Owen Devine; Nel Roeleveld; Jennita Reefhuis
Journal:  Paediatr Perinat Epidemiol       Date:  2014-08-26       Impact factor: 3.980

3.  Maternal stressful life events and risks of birth defects.

Authors:  Suzan L Carmichael; Gary M Shaw; Wei Yang; Barbara Abrams; Edward J Lammer
Journal:  Epidemiology       Date:  2007-05       Impact factor: 4.822

4.  Evaluation of prenatal diabetes mellitus and other risk factors for craniofacial microsomia.

Authors:  Babette Siebold; Carrie L Heike; Brian G Leroux; Matthew L Speltz; Amelia F Drake; Alexis L Johns; Kathleen A Kapp-Simon; Leanne Magee; Daniela V Luquetti
Journal:  Birth Defects Res       Date:  2019-03-30       Impact factor: 2.344

5.  Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: a validation study in the Netherlands.

Authors:  Marleen M H J van Gelder; Iris A L M van Rooij; Hermien E K de Walle; Nel Roeleveld; Marian K Bakker
Journal:  Drug Saf       Date:  2013-01       Impact factor: 5.606

6.  A population-based case-control teratologic study of oral dipyrone treatment during pregnancy.

Authors:  Ferenc Bánhidy; Nándor Acs; Erzsébet Puhó; Andrew E Czeizel
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

7.  Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.

Authors:  Marlene Anderka; Allen A Mitchell; Carol Louik; Martha M Werler; Sonia Hernández-Diaz; Sonja A Rasmussen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-11-19

8.  Markers of acculturation and risk of NTDs among Hispanic women in California.

Authors:  Suzan L Carmichael; Gary M Shaw; Jun Song; Barbara Abrams
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2008-11

9.  Risk of hypospadias in relation to maternal occupational exposure to potential endocrine disrupting chemicals.

Authors:  M Vrijheid; B Armstrong; H Dolk; M van Tongeren; B Botting
Journal:  Occup Environ Med       Date:  2003-08       Impact factor: 4.402

10.  Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.

Authors:  Kara N D Polen; Sonja A Rasmussen; Tiffany Riehle-Colarusso; Jennita Reefhuis
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.